# SERENEURO THERAPEUTICS, INC.: SN102: a Novel Gene Therapy for Trigeminal Neuralgia Pain

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | SERENEURO THERAPEUTICS, INC. |
| Location | BALTIMORE, MD |
| Project | SN102: a Novel Gene Therapy for Trigeminal Neuralgia Pain |
| Project number | 1R43DE035747-01 |
| Mechanism | R43 |
| Institute | National Institute of Dental and Craniofacial Research |
| Award | $338,115 |
| Awarded | 2026-09-23 |
| Project period | 2026-09-23 to 2027-09-22 |
| UEI | Y89DBCYUCMH1 |

## Why this score
- Award of $338,115.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11312165). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.